HEALTH TOPICS 
Should you skip your PSA test?
The science is uncertain for now, so arm yourself with deep knowledge of the pros and cons of prostate cancer screening.
In May 2012, the United States Preventive Services Task Force (USPSTF) issued its final report concerning screening for prostate cancer using the prostate-specific antigen (PSA) test. After weighing the evidence, the expert panel concluded that PSA screening for prostate cancer should not be offered routinely to men—typically as part of a regular physical exam. Screening means testing a seemingly healthy person for signs of a hidden disease, like prostate cancer.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.